News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Warnex Inc.'s Bioanalytical Services Division Acquires Two State-of-the-Art TSQ Vantage Mass Spectrometers
October 16, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LAVAL, QUEBEC--(Marketwire - October 16, 2008) - Warnex Inc. (TSX: WNX) announced today that its Bioanalytical Services division has acquired two state-of-the-art TSQ Vantage mass spectrometers from Thermo Fisher Scientific Inc.
Twitter
LinkedIn
Facebook
Email
Print
Thermo Fisher Scientific